Showing results (1-10 of 611) with videos related to
Sort By:
Pageof 62
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2013
Selecting and characterizing drug-resistant hepatitis C virus repliconInge Vliegen, Leen Delang, Johan NeytsAntimicrobial Agents and Chemotherapy|June 29, 2011
Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replicationLeen Delang, Inge Vliegen, Mathy Froeyen, et al.Journal of Hepatology|June 28, 2011
In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitorsLeen Delang, Inge Vliegen, Pieter Leyssen, et al.Current Topics in Microbiology and Immunology|March 7, 2013
Hepatitis C virus-specific directly acting antiviral drugsLeen Delang, Johan Neyts, Inge Vliegen, et al.European Heart Journal. Acute Cardiovascular Care|May 5, 2020
Medical treatment options for COVID-19Leen Delang, Johan NeytsAntiviral Research|June 30, 2015
Towards antivirals against chikungunya virusRana Abdelnabi, Johan Neyts, Leen DelangAntiviral Research|March 11, 2018
Favipiravir as a potential countermeasure against neglected and emerging RNA virusesLeen Delang, Rana Abdelnabi, Johan NeytsCurrent Opinion in Infectious Diseases|November 3, 2015
The future of antivirals: broad-spectrum inhibitorsYannick Debing, Johan Neyts, Leen DelangViruses|October 14, 2011
Antiviral therapy for hepatitis C virus: beyond the standard of careLeen Delang, Lotte Coelmont, Johan NeytsAntiviral Research|March 12, 2014
Are statins a viable option for the treatment of infections with the hepatitis C virus?Ben Verpaalen, Johan Neyts, Leen DelangPageof 62